Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

@article{Tsai2007AndrogenDT,
  title={Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.},
  author={Henry K. Tsai and Anthony V. D'Amico and Natalia Sadetsky and Ming-Hui Chen and Peter R Carroll},
  journal={Journal of the National Cancer Institute},
  year={2007},
  volume={99 20},
  pages={
          1516-24
        }
}
BACKGROUND We investigated whether androgen deprivation therapy (ADT) use is associated with an increased risk of death from cardiovascular causes in patients treated for localized prostate cancer. METHODS From the Cancer of the Prostate Strategic Urologic Research Endeavor database, data on 3262 patients treated with radical prostatectomy and 1630 patients treated with external beam radiation therapy, brachytherapy, or cryotherapy for localized prostate cancer were included in this analysis… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 236 CITATIONS, ESTIMATED 37% COVERAGE

Cardiovascular risk during hormonal treatment in patients with prostate cancer

  • Cancer management and research
  • 2011
VIEW 12 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Androgen deficiency and atherosclerosis: The lipid link.

VIEW 5 EXCERPTS
CITES RESULTS, METHODS & BACKGROUND
HIGHLY INFLUENCED

Cardiovascular effects of hormone therapy for prostate cancer

  • Drug, healthcare and patient safety
  • 2015
VIEW 14 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2007
2019

CITATION STATISTICS

  • 16 Highly Influenced Citations

  • Averaged 12 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006